These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tasimelteon: a melatonin receptor agonist for non-24-hour sleep-wake disorder. Johnsa JD; Neville MW Ann Pharmacother; 2014 Dec; 48(12):1636-41. PubMed ID: 25204464 [TBL] [Abstract][Full Text] [Related]
4. Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia. van der Heijden KB; Smits MG; van Someren EJ; Boudewijn Gunning W J Sleep Res; 2005 Jun; 14(2):187-94. PubMed ID: 15910516 [TBL] [Abstract][Full Text] [Related]
5. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders. Hardeland R Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175 [TBL] [Abstract][Full Text] [Related]
6. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement. Hughes RJ; Sack RL; Lewy AJ Sleep; 1998; 21(1):52-68. PubMed ID: 9485533 [TBL] [Abstract][Full Text] [Related]
7. Entrainment of free-running circadian rhythms by melatonin in blind people. Sack RL; Brandes RW; Kendall AR; Lewy AJ N Engl J Med; 2000 Oct; 343(15):1070-7. PubMed ID: 11027741 [TBL] [Abstract][Full Text] [Related]
8. Safety profile of tasimelteon, a melatonin MT1 and MT2 receptor agonist: pooled safety analyses from six clinical studies. Leger D; Quera-Salva MA; Vecchierini MF; Ogrizek P; Perry CA; Dressman MA Expert Opin Drug Saf; 2015; 14(11):1673-85. PubMed ID: 26393492 [TBL] [Abstract][Full Text] [Related]
9. Tasimelteon for the treatment of non-24-hour sleep-wake disorder. Neubauer DN Drugs Today (Barc); 2015 Jan; 51(1):29-35. PubMed ID: 25685859 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of Tasimelteon (HETLIOZ®) in the Treatment of Jet Lag Disorder Evaluated in an 8-h Phase Advance Model; a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Polymeropoulos CM; Mohrman MA; Keefe MS; Brzezynski JL; Wang J; Prokosch LS; Polymeropoulos VM; Xiao C; Birznieks G; Polymeropoulos MH Front Neurol; 2020; 11():611. PubMed ID: 32754110 [No Abstract] [Full Text] [Related]
11. Melatonin treatment effects on adolescent students' sleep timing and sleepiness in a placebo-controlled crossover study. Eckerberg B; Lowden A; Nagai R; Akerstedt T Chronobiol Int; 2012 Nov; 29(9):1239-48. PubMed ID: 23005039 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial. Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW; PLoS Med; 2018 Jun; 15(6):e1002587. PubMed ID: 29912983 [TBL] [Abstract][Full Text] [Related]
13. Circadian phase, sleepiness, and light exposure assessment in night workers with and without shift work disorder. Gumenyuk V; Roth T; Drake CL Chronobiol Int; 2012 Aug; 29(7):928-36. PubMed ID: 22823876 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia. Roth T; Soubrane C; Titeux L; Walsh JK; Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind. Emens JS; Eastman CI Drugs; 2017 Apr; 77(6):637-650. PubMed ID: 28229310 [TBL] [Abstract][Full Text] [Related]
17. Tasimelteon for treating non-24-h sleep-wake rhythm disorder. Nishimon S; Nishimon M; Nishino S Expert Opin Pharmacother; 2019 Jun; 20(9):1065-1073. PubMed ID: 30990759 [TBL] [Abstract][Full Text] [Related]
18. Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia. Hajak G; Rodenbeck A; Adler L; Huether G; Bandelow B; Herrendorf G; Staedt J; Rüther E Pharmacopsychiatry; 1996 Sep; 29(5):187-92. PubMed ID: 8895944 [TBL] [Abstract][Full Text] [Related]
19. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. Van der Heijden KB; Smits MG; Van Someren EJ; Ridderinkhof KR; Gunning WB J Am Acad Child Adolesc Psychiatry; 2007 Feb; 46(2):233-41. PubMed ID: 17242627 [TBL] [Abstract][Full Text] [Related]
20. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent. Wyatt JK; Dijk DJ; Ritz-de Cecco A; Ronda JM; Czeisler CA Sleep; 2006 May; 29(5):609-18. PubMed ID: 16774150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]